Chemoinformaics analysis of 16-Hydroxyingenol
| Molecular Weight | 364.438 | nRot | 2 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 19 |
| Exact Molecular Weight | 364.189 | nRing | 4 |
| Solubility: LogS | -2.852 | nHRing | 0 |
| Solubility: LogP | 0.478 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 56.8822 |
| nHD | 5 | BPOL | 28.9578 |
| QED | 0.433 |
| Synth | 6.555 |
| Natural Product Likeliness | 2.442 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.852 |
| HIA | 0.017 |
| CACO-2 | -5.576 |
| MDCK | 0.000296904 |
| BBB | 0.556 |
| PPB | 0.342974 |
| VDSS | 0.562 |
| FU | 0.347125 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.779 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.769 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.054 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.25 |
| CL | 2.697 |
| T12 | 0.535 |
| hERG | 0.038 |
| Ames | 0.029 |
| ROA | 0.902 |
| SkinSen | 0.645 |
| Carcinogencity | 0.717 |
| EI | 0.029 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.893 |
| Antiviral | Yes |
| Prediction | 0.608414 |